Nonetheless, recent evidence is suggesting that the elevated levels of serum Dkk1 at baseline were associated with poor prognosis 1 year after ischemic stroke, suggesting that initial Dkk1 levels in the serum could constitute a biomarker for ischemic stroke prognosis (Zhu Z. et al., 2019). Here, DKK1 is linked to ischemic stroke.